KeyBank
KEY
$21.21
+0.86%
KeyCorp is a bank holding company whose principal subsidiary, KeyBank, operates a 16-state branch footprint concentrated in Ohio, New York, and Washington, serving middle-market commercial clients alongside consumer banking through a hybrid community/corporate model with roughly $190 billion in assets. It is a super-regional lender rather than a money-center or pure consumer bank, deriving revenue from two roughly balanced segments — Commercial Bank ($1.108 billion) and Consumer Bank ($1.010 billion) — which gives it meaningful exposure to commercial credit conditions and net interest income sensitivity. The current investor debate centers on the durability of the net interest margin recovery: management raised its 2026 revenue outlook on confidence in loan growth and margin expansion, yet the stock has de-rated sharply since mid-year as falling benchmark rates and a soft Q2 revenue print (down 26.4% year over year) have raised questions about whether the earnings recovery is stalling. With a 4.7% dividend yield and a forward P/E near 9x, the narrative has shifted from cyclical recovery to a value-versus-value-trap argument, with sell-side ratings split between Overweight and Neutral.…
KEY
KeyBank
$21.21
Related headlines
Investment Opinion: Should I buy KEY Today?
Rating: Hold. The core thesis is that KEY is cheap on forward earnings (9.29x forward P/E versus 13.49x trailing) with a 4.66% dividend yield and 25.6% upside to the $25.105 average analyst target, but the Q2 2026 revenue decline of 26.39% YoY must stabilize before the forward discount can be trusted. The 'buy' consensus (mean 1.95 across 20 analysts) anchors a constructive view, but the stock's 15.12% three-month decline and -17.81 relative strength argue for patience rather than pre-empting a turn.
Supporting evidence: the forward P/E of 9.29x is below the 10x-13x typical regional bank range, P/B of 1.11x is mid-range versus its 0.62x-1.35x history, net margin improved to 24.72% from 15.19% a year ago, and TTM FCF of $1.199 billion gives a ~5.3% FCF yield. Debt-to-equity of 0.54 and ROA of 1.08% confirm balance sheet strength, and the $22.00 low analyst target sits 10.1% above the current price, limiting modeled downside.
Risks that could invalidate the thesis: a second consecutive quarter of revenue below $2.5 billion would confirm margin compression and likely cut the $2.45 EPS estimate; a break below the $19.79 support would target the $16.79 52-week low; and the 57.6% payout ratio limits dividend flexibility if earnings fall. This Hold would upgrade to Buy if Q3 revenue recovers above $2.5 billion and forward EPS holds near $2.45, or downgrade to Sell if revenue stays below $2.2 billion or the stock breaks $19.79. Valuation verdict: cheap on forward earnings, fair on book value, and expensive on distorted EBITDA metrics — fairly valued to modestly undervalued relative to history, but not yet a clear bargain.
Sign up to view all
KEY 12-Month Price Forecast
The forward-looking view is balanced: valuation is genuinely cheap at 9.29x forward earnings with a 4.66% dividend yield and 25.6% upside to the average target, but the Q2 revenue collapse and -$59 million EBITDA quarter mean the earnings estimate underpinning that discount is at risk. The stock's position near the bottom of its 52-week range with -17.81 three-month relative strength argues against catching the falling knife before confirmation. I would upgrade to bullish if Q3 revenue recovers above $2.5 billion and forward EPS holds near $2.45, and downgrade to bearish if revenue stays below $2.2 billion or the stock breaks the $19.79 support. The 50% base-case probability reflects that the most likely outcome is range-bound consolidation while the market waits for margin evidence.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on KeyBank's 12-month outlook, with a consensus price target around $25.11 and implied upside of +18.4% versus the current price.
Average Target
$25.11
0 analysts
Implied Upside
+18.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$22 - $43
Analyst target range
Coverage is robust with 20 analysts, and the consensus recommendation is "buy" with a mean rating of 1.95 (where 1.0 is a strong buy and 5.0 a strong sell), indicating a moderately bullish tilt. The average target price of $25.105 implies +25.6% upside from the current $19.99, and notably even the low target of $22.00 sits 10.1% above the current price — meaning no covering analyst models downside from here, a unanimity that is itself a contrarian caution flag given the stock's 15.1% three-month decline.\n\nThe target range of $22.00 to $43.00 is extremely wide — the high target is 95% above the low and 115% above the current price — signaling high uncertainty rather than strong conviction; a $43 target likely assumes substantial multiple re-rating toward 1.7x-1.8x book alongside the $2.45 EPS estimate, while the $22 low target prices in roughly flat book value and margin compression with no re-rating. Recent institutional actions show a stable-to-cautious pattern: Truist reiterated Hold on September 23, Stephens reiterated Overweight on September 15, and the July 22 post-earnings cluster included DA Davidson (Buy), KBW (Outperform), RBC (Outperform), and Baird (Neutral), with no upgrades or downgrades in the visible record — analysts are maintaining positions rather than adding conviction. The divergence between a "buy" consensus and a stock making new relative lows suggests estimates have not yet been cut to reflect the Q2 revenue weakness, and the risk is that targets drift toward the $22 low end if the next quarter does not show revenue stabilization.
Bulls vs Bears: KEY Investment Factors
The bear case currently has stronger near-term evidence: a 26.4% YoY revenue decline, a -$59 million EBITDA quarter, and 15.1% three-month underperformance against a rising market are concrete and recent. The bull case is built on forward estimates ($2.45 EPS, 9.29x forward P/E) and analyst targets ($25.105 average) that have not yet been marked down, making it contingent rather than confirmed. The single most important tension is whether Q2's revenue collapse was a one-time item or the start of margin compression; if Q3 shows revenue back above $2.5 billion, the forward discount is real, but if it confirms the decline, the 9.29x multiple is a value trap. Until that resolves, the risk/reward is balanced but the momentum and estimate-revision risk favor caution.
Bullish
- Deep forward P/E discount: At $19.99, KEY trades at 9.29x forward EPS of $2.45 versus a 13.49x trailing multiple, a 31% compression that prices in significant earnings growth. If consensus is delivered, the stock is cheap on an absolute basis for a profitable regional bank with 24.72% net margin.
- Analyst targets imply 25.6% upside: The 20-analyst consensus is 'buy' (mean 1.95) with an average target of $25.105, 25.6% above the current price. Even the low target of $22.00 is 10.1% above spot, meaning no covering analyst models downside.
- Solid balance sheet and FCF: Debt-to-equity is just 0.54, ROA is 1.08%, and TTM free cash flow is $1.199 billion, a ~5.3% FCF yield on the $22.6 billion market cap. The company repaid $2.348 billion of debt in Q2 2026, showing active deleveraging.
- Core segments are stable: Commercial Bank revenue of $1.108 billion and Consumer Bank of $1.010 billion are roughly balanced and stable; the Q2 weakness is concentrated in a -$154 million 'Other' drag and a -$59 million EBITDA line, not a collapse in lending.
Bearish
- Q2 revenue collapsed 26.4% YoY: Q2 2026 revenue of $2.059 billion fell 26.39% from $2.797 billion a year earlier, a sharp break from the prior five quarters clustered at $2.70-$2.86 billion. EBITDA swung to -$59 million from +$547 million, raising doubts about the earnings recovery.
- Severe relative underperformance: KEY is down 15.12% over 3 months and 8.30% over 6 months while the S&P 500 gained 2.69% and 7.48%, producing relative strength of -17.81 and -15.78. The stock sits at just 43.9% of its 52-week range, only 3.4% above the $16.79 low.
- Forward estimates may be too high: The bull case rests on $2.45 consensus EPS, but the Q2 revenue miss makes that estimate vulnerable to downward revision. The PEG ratio of -0.02 is meaningless and signals negative growth inputs, while the 13.90x EV/EBITDA looks elevated on distorted EBITDA.
- Analyst unanimity is a caution flag: Even the lowest analyst target ($22.00) is above the current price, yet the stock keeps making relative lows. This divergence suggests estimates have not yet been cut to reflect Q2 weakness, and targets could drift toward the low end.
KEY Technical Analysis
KeyCorp is in a clear intermediate downtrend despite a positive 1-year return of 19.13%, with the stock closing at $19.99 versus a 52-week range of $16.79 to $24.07 — putting it at just 43.9% of its 52-week range, in the lower half and only 3.4% above the 52-week low. The 1-year gain masks a deteriorating trajectory: the stock peaked near $23.99 in mid-July and has since given back roughly 17%, meaning the long-term uptrend has effectively rolled over into a lower-highs sequence. This positioning near the bottom of the range is a classic falling-knife setup rather than a momentum continuation, and the proximity to the 52-week low makes the $16.79 level the line in the sand for the bullish thesis.\n\nShort-term momentum is decisively negative and diverging from the still-positive 1-year trend: the stock is down 3.52% over 1 month, 15.12% over 3 months, and 8.30% over 6 months, while the S&P 500 gained 1.22%, 2.69%, and 7.48% over the same windows — relative strength of -4.74 (1M), -17.81 (3M), and -15.78 (6M) confirms severe underperformance. The 3-month decline of 15.12% is more than five times the 1-month decline, indicating the selling pressure was front-loaded in the August-September window (the stock fell from $23.31 on August 14 to $20.24 by September 23) and has since flattened into a low-volatility drift around $19.80-$20.20. That flattening after a sharp drop can signal either basing or a pause before the next leg lower; with no RSI provided, the absence of a bounce off the $20 round number after two weeks of consolidation argues against an oversold snapback.\n\nKey technical levels are well defined: support sits at the $19.79-$19.83 recent low (October 7 and October 14 closes) with the 52-week low of $16.79 as the ultimate floor, while resistance is the $23.99 July high and the $24.07 52-week high just above it. A breakdown below $19.79 would likely target the $18.50-$19.00 zone and put the 52-week low in play, whereas reclaiming the $21.20-$21.80 shelf (the September breakdown area) would be the first evidence of a trend repair. Beta of 1.087 means the stock is only about 9% more volatile than the market, so the 18.57% max drawdown is stock-specific rather than beta-driven, and with a short ratio of 2.13 and volume of 17.2 million shares, positioning is not crowded — which cuts both ways for a contrarian entry.
Beta
—
—
Max Drawdown
-18.6%
Largest decline past year
52-Week Range
$17-$24
Price range past year
Annual Return
+21.4%
Cumulative gain past year
| Period | KEY Return | S&P 500 |
|---|---|---|
| 1m | +3.6% | -1.2% |
| 3m | -6.4% | +3.4% |
| 6m | -1.9% | +7.0% |
| 1y | +21.4% | +14.4% |
| ytd | +1.1% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KEY Fundamental Analysis
The revenue trajectory is the central problem: Q2 2026 revenue of $2.059 billion fell 26.39% year over year from $2.797 billion, a dramatic deceleration from the sequential pattern of $2.698 billion (Q1 2025), $2.797 billion (Q2 2025), $2.833 billion (Q3 2025), $2.860 billion (Q4 2025), $2.728 billion (Q1 2026), and $2.059 billion (Q2 2026). The Q2 print is an outlier versus the prior five quarters, which clustered in a $2.70-$2.86 billion band, and the reported EBITDA of -$59 million (versus +$701 million in Q1 2026 and +$547 million in Q2 2025) suggests either a one-time item, a reclassification of interest expense, or genuine margin compression; investors need clarity here because a single anomalous quarter can distort the entire growth narrative. Segment data shows Commercial Bank at $1.108 billion and Consumer Bank at $1.010 billion with a -$154 million "Other" drag, indicating the core franchises are roughly stable and the weakness is concentrated in non-core/treasury items rather than a collapse in lending activity.\n\nProfitability remains solid at the net income line even as the operating line looks ugly: Q2 2026 net income was $509 million with a net margin of 24.72%, up from $425 million and a 15.19% margin in Q2 2025, and EPS of $0.44 versus $0.35 a year ago. Gross margin was 60.71% in Q2 2026 versus 60.53% in Q2 2025 and 67.41% in Q1 2026, while the operating margin swung to -2.87% from +25.70% in Q1 — a gap explained by the $706 million in total other income that offset the negative operating income, a structure typical of bank P&L presentation rather than a sign of operational failure. The trailing net margin of 16.35% and operating margin of 20.59% are respectable for a regional bank, and the EPS progression from $0.33 (Q1 2025) to $0.44 (Q2 2026) shows steady underlying earnings power even as headline revenue optics deteriorate.\n\nBalance sheet and cash flow metrics are the strongest part of the story: debt-to-equity is a modest 0.54, ROE is 8.97%, ROA is 1.08%, and TTM free cash flow is $1.199 billion, giving an FCF yield of roughly 5.3% on the $22.6 billion market cap. Liquidity is thin on a current-ratio basis at 0.77, but that metric is largely meaningless for a bank whose funding is deposit-based; more relevant is the $1.711 billion cash balance at Q2 2026 and the $2.348 billion of debt repayment during the quarter, which shows active deleveraging. The payout ratio of 57.6% against a 4.66% dividend yield is covered by earnings but leaves limited room for error, and quarterly FCF has been volatile ($233 million in Q2 2026, -$74 million in Q1 2026, $673 million in Q4 2025), so the company depends on capital markets access and deposit stability rather than purely internal cash generation to fund growth.
Quarterly Revenue
$2.1B
2026-06
Revenue YoY Growth
-26.4%
YoY Comparison
Gross Margin
60.7%
Latest Quarter
Free Cash Flow
$1.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KEY Overvalued?
Because KeyCorp is profitable (Q2 2026 net income of $509 million, TTM EPS positive), the P/E ratio is the appropriate primary metric; the trailing P/E is 13.49x while the forward P/E is just 9.29x, a 31% compression that implies the market expects earnings to grow meaningfully — consistent with consensus EPS of $2.45 versus the current run-rate. The gap between trailing and forward multiples is the entire bull case: if the $2.45 estimate is delivered, the stock at $19.99 is cheap on an absolute basis, but the 26.4% revenue decline in Q2 makes that estimate vulnerable to downward revision.\n\nOn peer comparison, the P/B ratio of 1.11x and P/S of 2.02x sit at modest levels for a regional bank, while the 4.66% dividend yield is well above the sector norm and the 13.49x trailing P/E is roughly in line with typical regional bank multiples in the 10x-13x range — neither a clear premium nor a deep discount. The EV/EBITDA of 13.90x and EV/Sales of 4.92x look elevated for a bank, but these metrics are distorted by the negative EBITDA quarter and are not the right lens for a deposit-funded lender; the more telling figure is the PEG ratio of -0.02, which is meaningless given the sign of the growth input and should be disregarded. Relative to its own history, the stock is not stretched: P/B has ranged from 0.62x (Q2 2023) to 1.35x (Q1 2022) and sits at 1.11x, while the trailing P/E of 13.49x compares with a historical band from roughly 7.2x (Q3 2022) to 19.4x (Q1 2024) — mid-range rather than extreme. The valuation therefore offers no margin-of-safety signal from history alone; the discount is in the forward multiple, and that discount is only real if the earnings estimate holds.\n\nAgainst its own historical band, the current 1.11x P/B is above the 0.92x-0.98x levels seen through 2024-2025 but below the 1.20x-1.35x peaks of 2021-2022, placing it in the middle of a multi-year range rather than at a cyclical extreme. The dividend yield of 4.66% is near the high end of its historical range (versus 1.0%-1.5% in 2021-2022 and 1.4%-1.7% in 2024), which mechanically reflects the price decline rather than a payout increase and is a classic signal that the market is pricing in either opportunity or deterioration. Net-net, the stock is cheap on forward earnings, fair on book value, and expensive on the distorted EBITDA metrics — a mixed picture that argues for waiting for confirmation of the revenue stabilization rather than pre-empting it.
PE
13.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the Q2 2026 revenue collapse of 26.39% YoY to $2.059 billion and a swing to -$59 million EBITDA from +$547 million a year earlier, which raises the possibility of genuine net interest margin compression rather than a one-time item. The 57.6% payout ratio against a 4.66% dividend yield leaves limited cushion if earnings decline, and quarterly FCF volatility ($233 million in Q2 2026 versus -$74 million in Q1 2026) means the dividend depends on deposit stability and capital markets access. Revenue is also concentrated in commercial lending (Commercial Bank $1.108 billion of the $2.059 billion total), exposing KEY to commercial credit deterioration in its Ohio, New York, and Washington footprint.
Market and competitive risks include valuation compression if the forward EPS estimate of $2.45 is cut; at 9.29x forward the stock is cheap only if that number holds, and a revision toward the $2.20 low estimate would push the multiple above 9x on lower earnings. The stock's beta of 1.087 means it is only ~9% more volatile than the market, so the 18.57% max drawdown is stock-specific, not macro-driven, and the -17.81 three-month relative strength shows active de-rating. Competitive pressure from larger money-center banks and fintech lenders in middle-market commercial banking could limit loan growth, while falling benchmark rates pressure net interest income, the core of the raised 2026 revenue outlook.
Worst-case scenario: Q3 2026 confirms the revenue decline, consensus EPS is cut toward $2.20, and the stock breaks the $19.79-$19.83 October support, targeting the $18.50-$19.00 zone and putting the $16.79 52-week low in play. From $19.99, a move to $16.79 represents a -16.0% loss, and a re-rating to the historical low P/B of 0.62x (Q2 2023) would imply a price near $11.20, a -44% drawdown. A more realistic adverse case is a retest of the 52-week low, a -16% loss, with the $22.00 analyst low target providing the upside boundary in that scenario.
FAQ
The most severe risk is earnings revision: Q2 2026 revenue fell 26.39% YoY to $2.059 billion and EBITDA swung to -$59 million, and if Q3 confirms the decline, the $2.45 consensus EPS could be cut toward the $2.20 low estimate, undermining the 9.29x forward P/E thesis. Second is technical breakdown risk: the stock sits only 3.4% above its $16.79 52-week low, and a break below the $19.79-$19.83 support would target $18.50-$19.00 and put the low in play, a -16% move. Third is dividend sustainability: the 57.6% payout ratio leaves limited cushion, and quarterly FCF volatility ($233 million in Q2 2026 versus -$74 million in Q1 2026) means a payout cut is possible if earnings fall. Fourth is macro and rate risk: falling benchmark rates pressure net interest income, the core of the raised 2026 revenue outlook, and the 1.087 beta offers little diversification benefit.
The 12-month forecast has three scenarios: a 25% bull case targeting $25.00-$27.00 if Q3 revenue rebounds above $2.5 billion and the $2.45 EPS holds, a 50% base case targeting $21.00-$23.00 if revenue stabilizes in the $2.2-$2.5 billion range, and a 25% bear case targeting $16.79-$19.00 if revenue stays below $2.2 billion and the stock breaks $19.79 support. The base case is most likely, anchored by the $22.00 low analyst target as a floor and the $23.99 July high as resistance. The key assumption behind the base case is that Q2's revenue collapse was a one-time item rather than the start of sustained margin compression, which the next quarterly print will confirm or refute.
KEY looks undervalued on forward earnings but fairly valued on book: the 9.29x forward P/E is below the 10x-13x typical regional bank range and well below its 13.49x trailing multiple, while the 1.11x P/B sits mid-range versus its 0.62x-1.35x history. The 4.66% dividend yield is near the high end of its historical range, mechanically reflecting the price decline rather than a payout increase. The market is paying a discount that implies it expects the $2.45 consensus EPS to be delivered, so the valuation is only genuinely cheap if Q2's revenue weakness proves temporary. On distorted metrics like the 13.90x EV/EBITDA the stock looks expensive, but that is an artifact of the negative EBITDA quarter and not the right lens for a deposit-funded bank.
From a risk/reward perspective, KEY offers 25.6% upside to the $25.105 average analyst target against roughly 16% downside to the $16.79 52-week low, a roughly 1.6:1 reward-to-risk ratio that is attractive but not compelling. The 9.29x forward P/E and 4.66% dividend yield provide valuation support, and the $22.00 low analyst target sits 10.1% above the current price, meaning no covering analyst models downside. However, the 26.39% Q2 revenue decline and -$59 million EBITDA quarter mean the forward earnings estimate is unconfirmed, and the stock's -17.81 three-month relative strength shows active de-rating. It is a good buy for income-oriented, patient investors who can tolerate a retest of the $16.79 low, but only after Q3 revenue shows stabilization above $2.5 billion.
KEY is better suited to a long-term holding period of at least 12-18 months than to short-term trading, given its 4.66% dividend yield, 1.087 beta, and the need for at least one or two quarters of revenue stabilization to validate the forward earnings thesis. The stock is in a clear intermediate downtrend with -17.81 three-month relative strength and sits near the bottom of its 52-week range, making short-term momentum trading unfavorable until it reclaims the $21.20-$21.80 shelf. Long-term investors are compensated by the dividend and the 9.29x forward P/E, but the 57.6% payout ratio and volatile FCF mean earnings visibility is limited, so position sizing should account for a potential retest of the $16.79 low. A minimum holding period of 12 months aligns with the next two to three earnings cycles needed to confirm the margin recovery.